Cynata Therapeutics treats final patient in stem cell clinical trial – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics treats final patient in stem cell clinical trial
Proactive Investors Australia Cynata's vice president of product development Dr Kilian Kelly said: “Treating the final patient in the phase I trial of our novel CYP-001 stem cell therapy in GvHD represents a significant milestone and great achievement for Cynata. “In an analysis of … |
